MHRA grants conditional authorisation for treatment targeting mantle cell lymphoma
Category: News
The US Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application from Coya Therapeutics […]
Encare’s ERAS Interactive Audit System (EIAS) has earned qualification on the Mayo Clinic Platform_Solutions Studio – a distinction […]
HUTCHMED has announced that Weiguo Su, CEO of the company, will take a leave of absence from his […]
Novartis has reported that its experimental drug ianalumab met the primary goal in a phase 3 trial for […]
Eli Lilly and Company has announced that Anne White, executive vice president and president of Lilly Neuroscience, will […]
ANGLE has announced a collaboration with Myriad Genetics to assess whether circulating tumour cell (CTC) DNA harvested from […]
Friends of Cancer Research has announced a new collaboration with global clinical research organisation, MMS, to develop decision […]
Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable Platform Funding Call to support the […]
